Autres langues Prestige Consumer Healthcare Inc.

Actions

PBH

US74112D1019

Temps réel estimé Cboe BZX Autres places de cotation 17:44:49 26/04/2024			Varia. 5j.	Varia. 1 janv.
70,11 ^USD	-0,04 %		+0,66 %	+14,55 %

16/02	Un initié de Prestige Consumer Healthcare a vendu des actions pour une valeur de 1 766 665 $, selon un récent dépôt auprès de la SEC	MT
16/02	Un initié de Prestige Consumer Healthcare a vendu des actions pour une valeur de 2 051 874 $, selon un récent dépôt auprès de la SEC	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Prestige Consumer Healthcare : Clawback Policy	25/04
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results	25/04
Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag	03/04
Prestige Consumer Healthcare : Consumer Analyst Group of New York (CAGNY) 2024 Luncheon Presentation	07/03
Prestige Consumer Healthcare Insider Sold Shares Worth $1,766,665, According to a Recent SEC Filing	16/02
Prestige Consumer Healthcare Insider Sold Shares Worth $2,051,874, According to a Recent SEC Filing	16/02
Prestige Consumer Healthcare Insider Sold Shares Worth $368,184, According to a Recent SEC Filing	12/02
Prestige Consumer Healthcare's Fiscal Q3 Earnings, Revenue Increase; Raises 2024 Earnings Guidance; Shares Gain	08/02
North American Morning Briefing : S&P 500 to Open -2-	08/02
Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Reports Q3 Revenue $282.7M, vs. Street Est of $280.4M	08/02
Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Reports Q3 EPS $1.06, vs. Street Est of $1.04	08/02
Prestige Consumer Healthcare: Fiscal Q3 Earnings Snapshot	08/02
Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results	08/02
Prestige Consumer Healthcare Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08/02
Prestige Consumer Healthcare Inc. Revises Earnings Guidance for the Year of Fiscal 2024	08/02
Prestige Consumer Healthcare Unit Recalls 2 Lots of Ting Antifungal Spray Liquid on High Levels of Benzene	02/02
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene	02/02
Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene	02/02
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results	10/01
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results	10/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Prestige Consumer Healthcare Inc.

Actions

PBH

US74112D1019

Autres langues

Filtres